Sapu Bioscience expands Sapu003 Phase 1b program with Global Clinical Trials as lead CRO
June 08, 2026 | 11:09
Sapu Bioscience has announced the expansion of its Phase 1b clinical development program for Sapu003 and the appointment of Global Clinical Trials as lead contract research organization for the international program.
Latest News
Mobile Version